- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03257371
A Biologic Joint Replacement Strategy to Treat Patients With Severe Knee Trauma and Post-Traumatic Knee Osteoarthritis
With IRB approval and informed consent, patients (n=10) (18-50 years old) with post-traumatic knee OA and requiring a tibial plateau and meniscus arthroplasty plus a femoral condyle arthroplasty will be enrolled in the study. Primary criteria for inclusion will be Grade IV changes in the articular cartilage of the femoral condyle and tibial plateau and meniscal pathology in the medial or lateral femorotibial joint as determined by physical examination, diagnostic imaging and knee arthroscopy by the PI. Exclusion criteria include Grade III or IV changes in any other compartment of the knee, acute injury to any other part of the affected lower extremity, or inability to comply with the protocol.
After enrollment, patients will undergo standardized knee radiography, and complete assessments (described below). Size-matched (standard clinical methodology) proximal tibia with meniscus and distal femur allografts from the same donor will be obtained from a tissue bank (Musculoskeletal Transplant Foundation, Edison, NJ) who has licensed the MOPS technology. The medial or lateral femoral condyle will be replaced using our novel instrumentation and technique described above. Tibial plateau-meniscus grafts will be trimmed and used to replace the entire medial or lateral tibial condyle while sparing the attachments of ACL, PCL and respective collateral ligament. The tibial plateau graft will be fixated using commercial available implants used for bone fixation. In the event that the meniscus has been detached from the tibial plateau during graft harvest, the periphery of the meniscus will be sutured to the capsule following standard meniscus transplant procedure.
Patients will undergo controlled post-operative rehabilitation according to standard protocols for osteochondral with concurrent meniscus allografts.
Range of motion, VAS pain score, SF-12, Tegner score, International Knee Documentation Committee (IKDC) subjective and objective scores, PROMIS Bank v1.2 - Physical Function-Mobility, PROMIS v1.1 - Global Health, PROMIS Bank v1.1- Pain Interference, PROMIS Bank v1.2 - Physical Function and Marx score as well as complete radiographs of the affected knee will be obtained prior to surgery and at 6 weeks, 3 months, 6 months, and 12 months after surgery to evaluate healing, function and evidence for arthrosis.
Descripción general del estudio
Estado
Condiciones
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Missouri
-
Columbia, Missouri, Estados Unidos, 65212
- Missouri Orthopaedic Institute
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Patient requiring repair via tibial plateau and meniscus arthroplasty plus a femoral condyle arthroplasty
- The subject is able and willing to consent to participate in the study
Exclusion Criteria:
- Acute injury to any other part of the affected lower extremity
- The subject is unwilling, or unable to consent due to psychiatric condition or legal incompetence
- BMI > 40
- Age > 50 at the time of enrollment
- The subject is either pregnant, or a prisoner
- Currently involved in a workers' compensation case at the time of enrollment
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: Grupo
- Perspectivas temporales: Futuro
Cohortes e Intervenciones
Grupo / Cohorte |
|---|
|
Post-traumatic knee OA
post-traumatic knee OA and requiring a tibial plateau and meniscus arthroplasty plus a femoral condyle arthroplasty
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Visual Analogue Scale Pain Score
Periodo de tiempo: 12 months
|
patient reported Visual Analogue Scale Pain Score, 0 no pain, 10 maximum pain
|
12 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Tegner Activity Level Scale
Periodo de tiempo: 12 months
|
Patient reported outcome scale related to work and sporting activities, The Tegner activity scale is a one-item score that graded activity based on work and sports activities on a scale of 0 to 10. Zero represents disability because of knee problems and 10 represents national or international level soccer.
|
12 months
|
|
International Knee Documentation Committee (IKDC) Total Score
Periodo de tiempo: 12 months
|
Knee specific patient reported outcome, ranges from 0 to 100.
This final number is interpreted as a measure of function with higher scores representing higher levels of function.
|
12 months
|
|
PROMIS - Physical Function and Mobility
Periodo de tiempo: 12 months
|
A survey related to physical function and mobility, T-score metric in which 50 is the mean of a relevant reference population and 10 is the standard deviation (SD) of that population. On the T-score metric: A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population. A higher score is better for this outcome measure as it indicates more function/mobility compared to the mean of the reference population. |
12 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: James Stannard, MD, University of Missouri, Department of Orthopaedic Surgery
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 2002751
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Artrosis postraumática
-
Boston Children's HospitalTerminadoDolor post-amigdalectomía | Actividad Post-amigdalectomía | Hidratación Post-amigdalectomíaEstados Unidos
-
Novartis PharmaceuticalsReclutamientoMielofibrosis primaria (PMF) | Post-policitemia Vera Mielofibrosis (Post-PV MF) | Mielofibrosis post-trombocitemia esencial (MF post-ET)Japón
-
IHU StrasbourgRhythm Diagnostic SystemsTerminadoCirugía Visceral y Digestiva | Monitoreo Post-quirúrgico | Rehabilitación Post-quirúrgicaFrancia
-
Cairo UniversityAún no reclutando
-
Cairo UniversityReclutamiento
-
Rene RizzoliTerminado
-
Wyeth is now a wholly owned subsidiary of PfizerTerminadoPost menopausiaEstados Unidos
-
Wyeth is now a wholly owned subsidiary of PfizerTerminado
-
Wyeth is now a wholly owned subsidiary of PfizerTerminadoPost menopausiaEstados Unidos
-
Solvay PharmaceuticalsTerminadoPost menopausiaCroacia, Rumania, Polonia, Ucrania